Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Human antibodies that bind CD22 and uses thereof

Human antibodies that bind CD22 and uses thereof

US Patent 9499632 · Granted Nov 22, 2016

Estimated economic value: $615,837,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies modified for transglutaminase conjugation, conjugates thereof, and me2025
Compositions comprising anti-NRP2 antibodies2025
Antibodies directed against interleukin 36 receptor (IL-36R)2025
Anti-IL-18BP antibodies2025
Method of treating an interleukin-11-associated or -mediated fibrotic disease or2025
Anti-PVRIG antibodies and methods of use2025
Antibody comprising a glutamine-containing light chain C-terminal extension, con2025
Antibodies directed to Tie-2 and methods of use2025
Anti-interleukin-11 receptor subunit α (IL-11Rα) antibodies2024
Compositions and methods comprising anti-NRP2 antibodies2024
Method of treating autoimmune disease with antibodies against IL-332024
Therapeutic compositions comprising anti-NRP2 antibodies2023